Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma
September 2nd 1997Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided